Abstract
Depression in old age frequently follows a chronic and/or relapsing course, related to medical comorbidity, cognitive impairment and depletion of psychosocial resources. As endorsed by the US National Institutes of Health (NTH) Consensus Development Conference on the Diagnosis and Treatment of Late Life Depression, a major goal of treatment is to prevent relapse, recurrence and chronicity.
We believe that most, if not all, elderly patients with major depressive episodes are appropriate candidates for maintenance therapy, because of the vulnerability to relapse and recurrence and because of the favourable benefit to risk ratio of available treatments. Antidepressant pharmacotherapy is the mainstay of this therapeutic goal, but psychosocial approaches (especially interpersonal psychotherapy) have also been shown to contribute significantly to prevention of a chronic depressive illness and to prevention of the disability that attends depression.
Studies published to date have established the long term or maintenance efficacy of the tricyclic antidepressant nortriptyline. Current, ongoing studies are addressing the maintenance efficacy of paroxetine and citalopram to prolong recovery in depression associated with old age. These studies are focusing particularly on patients aged 70 years and above, who are at high risk of recurrence, and on patients in primary care settings, where under-recognition and under-treatment of depression in the elderly have been costly from a public health perspective in terms of increased medical utilisation, burden to patients and families, and high rates of suicide.
Depression in old age is a major contributor to the global burden of illness-related disability, but it is extremely treatable if appropriate pharmacotherapy is prescribed and accepted by patients and their caregivers.
Similar content being viewed by others
References
Mulsant BH, Ganguli M. Epidemiology and diagnosis of depression in late-life. J Clin Psychiatry 1999; 60 Suppl.: 9–15
Rovner BW, German PS, Brant LJ, et al. Depression and mortality in nursing homes [published erratum appears in JAMA 1991 May 22–29; 265 (20): 2672; see comments]. JAMA 1991; 265(8): 993–6
Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction, impact on 6-month survival. JAMA 1993; 270: 1819–25
Wells KB, Burnam MA. Caring for depression in America: lessons learned from early findings of the Medical Outcomes Study. Psychiatr Med 1991; 9: 503–19
Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study [see comments]. JAMA 1989; 262(7): 914–9
World Health Organization. Global health statistics: a compendium of incidence, prevalence and mortality estimates for over 200 conditions: the global burden of disease. Cambridge (MA): Harvard University Press, 1996
Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999; 156(7): 1000–6
Zis AP, Grof P, Webster M. Predictors of relapse in recurrent affective disorders. Psychopharmacol Bull 1980; 16: 47–9
Georgotas A, McCue RE. Relapse of depressed patients after effective continuation therapy. J Affect Disord 1989; 17: 159–64
Reynolds CF, Frank E, Dew MA, et al. Treatment in 70+ year olds with major depression: excellent short-term but brittle long-term response. Am J Geriatr Psychiatry 1999; 7(1): 64–9
Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999; 281(1): 39–45
Flint AJ, Rifat SL. Maintenance treatment for recurrent depression in late-life. Am J Geriatr Psychiatry 2000; 8: 112–6
Lenze EJ, Rogers JC, Martire LM, et al. The association of late-life depression and anxiety with physical disability: a review of the literature and prospectus for future research. Am J Geriatr Psychiatry 2001; 9(2): 113–35
Alexopoulos G, Vrontou C, Kakuma T, et al. Disability in geriatric depression. Am J Psychiatry 1996; 153: 877–85
Reynolds CF, Miller MD, Pasternak RE, et al. Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry 1999; 156(2): 202–8
Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. JAMA 1989; 262: 1479–84
Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression. Am J Psychiatry 1997; 154(4): 562–5
Dew MA, Reynolds CF, Houck PR, et al. Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 1997; 54: 1016–24
Harman JS, Reynolds CF. Removing the barriers to effective depression treatment in old age [editorial]. J Am Geriatr Soc 2000; 48(8): 871–7
Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late-life: consensus statement update. JAMA 1997; 278(14): 1186–90
Old Age Depression Interest Group (OADIG). How long should the elderly take antidepressants? A double-blind, placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry 1993; 162: 175–82
Reynolds CF, Frank E, Perel JM, et al. Treatment of consecutive episodes of major depression in the elderly. Am J Psychiatry 1994; 151(12): 1740–3
Dew MA, Reynolds CF, Mulsant B, et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. J Affect Disord 2001; 65: 155–66
Opdyke KS, Reynolds CF, Begley AE, et al. The effects of continuation treatment on residual symptoms of late-life depression: how well is ‘well?’. Depress Anxiety 1997; 4(6): 312–9
Reynolds CF, Frank E, Houck PR, et al. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? Am J Psychiatry 1997; 154(7): 958–62
Montgomery SA, Kasper S. Depression: a long-term illness and its treatment. Int Clin Psychopharmacol 1998; 13Suppl. 6: S23–6
Alexopoulos GS, Meyers BS, Young RC, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000; 57(3): 285–90
Flint AJ, Rifat SL. Two-year outcome of elderly patients with anxious depression. Psychiatry Res 1997; 66(1): 23–31
Amore M, Ricci M, Zanardi R, et al. Long-term treatment of geropsychiatric depressed patients with venlafaxine. J Affect Disord 1997; 46(3): 293–6
Montgomery SA. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients. Int Clin Psychopharmacol 1998; 13Suppl. 5: S49–54
Dunner DL. An overview of paroxetine in the elderly. Gerontology 1994; 40Suppl. 1: 21–7
Schneider LS. Treatment of depression in late life. Dialogues Clin Neurosci 1999; 1: 113–24
Bump GM, Mulsant BH, Pollock BG, et al. Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly. Depress Anxiety 2001; 13: 38–44
Alexopoulos GS, Meyers BS, Young RC, et al. Recovery in geriatric depression. Arch Gen Psychiatry 1996; 53: 305–12
Reynolds CF, Perel JM, Frank E, et al. Three year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels. Am J Psychiatry 1999; 156(8): 1177–81
Tew Jr HD, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999; 156: 1865–70
Little JT, Reynolds CF, Dew MA, et al. How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? Am J Psychiatry 1998; 155(8): 1035–8
Reynolds CF, Frank E, Perel JM, et al. High relapse rates after discontinuation of adjunctive medication in elderly patients with recurrent major depression. Am J Psychiatry 1996; 153(11): 1418–22
Reynolds CF, Kupfer DJ. Depression and aging: a look to the future. Psychiatr Serv 1999; 50(9): 1167–72
Williams JW, Barrett J, Oxman T, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 2000; 284: 1519–26
Bruce ML, Pearson JL. Designing an intervention to prevent suicide: PROSPECT (Prevention ofSuicide in Primary Care Elderly: Collaborative Trial). Dialogues Clin Neurosci 1999; 1(2): 100–12
Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologic treatment of chronic insomnia. Sleep 1999; 22(8): 1134–56
Prigerson HG, Monk TH, Reynolds CF, et al. Lifestyle regularity and activity levels as protective factors against bereavement-related depression. Depression 1996; 3(6): 297–302
Acknowledgements
Supported in part by National Institute of Mental Health (NIMH) Intervention Research Centers for Late Life Mood Disorders at the University of Pittsburgh (Dr Reynolds; P30 MH52247), Cornell Medical College (Dr Alexopoulos; P30 MH 49762) the University of Pennsylvania (Dr Katz; P30 MH 52129) and by the PROSPECT study (MH59381, MH59380, MH59366).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reynolds, C.F., Alexopoulos, G.S., Katz, I.R. et al. Chronic Depression in the Elderly. Drugs & Aging 18, 507–514 (2001). https://doi.org/10.2165/00002512-200118070-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200118070-00004